Universe Pharmaceuticals Inc
NASDAQ:UPC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
Universe Pharmaceuticals Inc
NASDAQ:UPC
|
CN |
|
C
|
Cellcom Israel Ltd
TASE:CEL
|
IL |
|
Atlanta Braves Holdings Inc
F:E450
|
US |
Intrinsic Value
The intrinsic value of Universe Pharmaceuticals Inc (UPC) under the Base Case is 1.2372 USD per share. Compared with the current market price of 4.1899 USD, the stock appears Overvalued by 70% .
The intrinsic value is calculated using the DCF method. Net margin recovers from -21% last year to -4.6% by 2030. If net margin stayed at its five-year average of -15%, the estimate would be about $0.82. The forecast years subtract value, so the estimate rests entirely on the years after 2030.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Universe Pharmaceuticals Does
Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 216 full-time employees. The company went IPO on 2021-03-23. The Company’s products include chronic condition treatments and cold and flu medicines. The chronic condition treatments primarily include Guben Yanling Pill, Shenrong Weisheng Pill, Quanlu Pill, Yangxue Danggui Syrup, Wuzi Yanzong Oral Liquid, Fengtong Medicinal Liquor, Shenrong Medicinal Liquor, Qishe Medicinal Liquor, Fengshitong Medicinal Liquor, and Shiquan Dabu Medicinal Liquor.
- Headquarters
- China CN
- Employees
- 216
- IPO date
- Mar 23, 2021
Earnings Waterfall
Universe Pharmaceuticals Inc
The intrinsic value for Universe Pharmaceuticals Inc (UPC) under the Base Case is 1.2372 USD.
Compared with the current market price of 4.1899 USD, the stock appears Overvalued by 70% .